AE1-BHK cell line

  • • Based on widely used BHK-21
  • • Existing plasmids and transfection processes for rAAV production
  • • BHK origin avoids ethical concerns
Download our fact sheet

Cell lines for research, biomanufacturing and viral vector production

Agathos AE1-BHK has been developed for recombinant adeno-associated virus (rAAV) production and other biomanufacturing and research applications that benefit from a mammalian cell expressing the adenovirus E1 gene.

AE1-BHK was developed by transfecting adenovirus E1 genes with selective pressure using hygromycin.

Using existing plasmids and triple transfection techniques AE1-BHK was used to produce rAAV.

rAAV2-GFP genomes from triple transfection of AE1-BHK cells are detected via digital PCR (QIAGEN Qiacuity)

Fluorescent (top) and fluorescent merged with bright field (bottom) images of HepG2 cells transduced with rAAV2-GFP from AE1-BHK.

Beyond HEK293

Ethics Meets Excellence

Choosing AE1-BHK for Your Research Needs:
Agathos Biologics is at the forefront of ethical biomanufacturing. We developed the AE1-BHK cell line to avoid ethical concerns that arise from using cells derived from embryonic stem cells or aborted fetal tissue as is the case for HEK293. Consumers and researchers alike are becoming more aware of how products and services are delivered and are demanding companies provide not just quality, but also principled business practices. Embrace a conscientious choice for your research needs, where ethics seamlessly align with exceptional products, setting a new industry standard for research and biomanufacturing.

Learn more about the AE1-BHK Cell Line
Receive samples of AE1-BHK free of charge* for evaluation!

*AE1-BHK cells are provided for research use only at no charge under a limited use label license (LULL). Commercial use requires a commercial license. Clients are charged shipping and handling only and shipments are limited to the continental United States.

"*" indicates required fields

* Mandatory field
By submitting this form you agree to Agathos holding the information securely and for us to send you information we think may be of interest. We will not share or sell your information with other companies or organizations.